He also highlighted a recent FCC ruling that expanded the “covered list” beyond expectations. Rubin said the ruling added to the FCC covered list all drones and critical components used in any country outside the U.S., including cameras and sensors. He said the company’s U.S.-made optical assemblies are already compliant and used in drones, while the company is still evaluating the role it may play in drone cameras beyond optics, including potential opportunities for larger drones and the challenges of aggr ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential investment opportunities before the market opens [1] Group 1: Premarket Gainers - Smart Logistics Global Limited (SLGB) is up 198% at $3.67 [3] - Brand Engagement Network, Inc. (BNAI) is up 67% at $10.29 [3] - Boxlight Corporation (BOXL) is up 56% at $1.96 [3] - Moolec Science SA (MLEC) is up 51% at $6.64 [3] - Anteris Technologies Global Corp. (AVR) is up 15% at $6.63 [3] - Hycroft Mining Holding Corporation (HYMC) is up 10% at $47.20 [3] - Nathan's Famous, Inc. (NATH) is up 8% at $100.94 [3] - Progress Software Corporation (PRGS) is up 6% at $41.05 [3] - LightPath Technologies, Inc. (LPTH) is up 5% at $14.81 [3] - ZenaTech, Inc. (ZENA) is up 5% at $4.33 [3] Group 2: Premarket Losers - Top Wealth Group Holding Limited (TWG) is down 29% at $3.81 [4] - Solo Brands, Inc. (SBDS) is down 21% at $5.25 [4] - GlucoTrack, Inc. (GCTK) is down 19% at $3.07 [4] - Galaxy Payroll Group Limited (GLXG) is down 19% at $2.26 [4] - INVO Fertility, Inc. (IVF) is down 13% at $2.04 [4] - Black Titan Corporation (BTTC) is down 11% at $2.11 [4] - Envirotech Vehicles, Inc. (EVTV) is down 10% at $3.30 [4] - Erasca, Inc. (ERAS) is down 6% at $9.21 [4] - ENDRA Life Sciences Inc. (NDRA) is down 6% at $4.31 [4] - Bonk, Inc. (BNKK) is down 6% at $3.74 [4]

Group 1 - LightPath Technologies Inc. has been identified as a promising tech stock, with Lake Street raising its price target from $10 to $14 while maintaining a Buy rating [1] - The company reported a 79% year-over-year revenue increase in FQ1 2026, reaching $15.1 million, up from $8.4 million in the same period last year [2] - LightPath's backlog reached a record $90 million, with over two-thirds consisting of complex systems, indicating a successful transition to high-value infrared systems [2][3] Group 2 - The proprietary BlackDiamond/G5 glass, a germanium-free material, is key to LightPath's growth, addressing supply chain vulnerabilities as global restrictions on germanium increase [3] - New contracts have been secured, including an $18.2 million order for delivery in 2026 and a follow-on $22.1 million order for 2027, highlighting the company's expansion in the drone sector [3] - An $8 million investment from Ondas and Unusual Machines will help accelerate LightPath's presence in the drone and UAV infrared imaging market [3]

Company Performance - Ultragenyx Pharmaceutical Inc. shares fell 42% to $19.84 following the announcement of Phase 3 study results for setrusumab (UX143) in Osteogenesis Imperfecta (OI) [1] - Mereo BioPharma Group plc shares dropped 90% to $0.23 after its Phase 3 studies for setrusumab did not achieve statistical significance against primary endpoints [5] Market Movements - Republic Power Group Ltd surged 163% to $0.69 [5] - Brand Engagement Network Inc jumped 84.3% to $2.21 after entering a Vendor Services Project Agreement [5] - DigitalBridge Group Inc rose 9.9% to $15.30 following the announcement of its acquisition by SoftBank Group for approximately $4.0 billion [5] Precious Metals Sector - Hycroft Mining Holding Corporation was down 14% to $21.61 as precious metal stocks traded lower due to a retreat in commodity prices [6] - Silver prices pulled back after reaching an all-time high, impacting related stocks [6]

Group 1 - U.S. stocks experienced a decline, with the Nasdaq Composite dropping over 100 points on Monday [1] - DigitalBridge Group Inc announced its acquisition by SoftBank Group for an enterprise value of approximately $4.0 billion, resulting in a 9.9% increase in its shares to $15.30 [1] Group 2 - Eightco Holdings Inc shares surged 29.1% to $2.15 following the announcement of a share buyback program for up to $125 million [2] - Palisade Bio Inc saw an 18.6% increase to $2.55 after Piper Sandler initiated coverage with an Overweight rating and a price target of $25 [2] - Regencell Bioscience Holdings Ltd gained 16.3% to $24.60 [2] - Praxis Precision Medicines Inc surged 13% to $304.00 after receiving Breakthrough Therapy Designation from the FDA for ulixacaltamide [2] - Zura Bio Ltd increased by 13% to $5.26 [2] - Precigen Inc rose 8.6% to $4.52 [2] - Autolus Therapeutics PLC jumped 7.8% to $1.80, with Needham analyst raising the price target from $10 to $11 [2] - LightPath Technologies Inc gained 6.6% to $9.62 [2] - NGL Energy Partners LP surged 6.3% to $9.98 [2] - Six Flags Entertainment Corp increased by 5% to $15.64 [2]

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Friday.Shares of Broadcom Inc (NASDAQ:AVGO) fell sharply in pre-market trading even after the semiconductor giant delivered fourth-quarter earnings beat and reported record artificial intelligence (AI) revenue.Despite a 74% surge in AI sales, investors focused heavily on disappointing guidance regarding shrinking gross margins and a sharply higher tax rate for fiscal 2026.Broadcom shares dipped 5% to $386.28 in pre ...

Core Insights - Lululemon Athletica Inc reported better-than-expected third-quarter results, with earnings of $2.59 per share, surpassing analyst estimates of $2.27 by 14.15% [1] - The company's quarterly revenue reached $2.57 billion, exceeding the Street estimate of $2.48 billion and showing an increase from $2.4 billion in the same period last year [1] - Following the positive earnings report, Lululemon raised its full-year guidance and announced a CEO succession plan along with an increase in its share buyback program [2] Stock Performance - Lululemon shares rose 9% to $203.82 in pre-market trading after the earnings announcement [2] - Other notable stock movements included cbdMD, Inc. gaining 57.6% and Paranovus Entertainment Technology Ltd. surging 52.2% in pre-market trading [5]

Group 1: LightPath Technologies Inc - LightPath Technologies Inc (NASDAQ:LPTH) reported better-than-expected first-quarter financial results, leading to a sharp rise in its shares during pre-market trading [1] - The company reported a quarterly loss of 7 cents per share, which was better than the analyst estimate of a 9-cent loss [1] - Quarterly revenue for LightPath Technologies was $15.05 million, surpassing the consensus estimate of $12.66 million [1] - Following the financial results, shares of LightPath Technologies jumped 6.8% to $8.58 in pre-market trading [1] Group 2: Other Stocks in Pre-Market Trading - Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) surged 170% to $2.65 after releasing pricing details for its underwritten public offering [6] - Kandal M Venture Limited (NASDAQ:FMFC) gained 70.4% to $0.9490 after previously falling 8% [6] - Amaze Holdings, Inc. (NYSE:AMZE) rose 68.4% to $0.8934 after extending its partnership with Adobe Express [6] - VCI Global Limited (NASDAQ:VCIG) surged 44.4% to $1.88 after a 27% dip on Tuesday [6] - Clearmind Medicine Inc. (NASDAQ:CMND) gained 27% to $0.5830 after a 32% decline on Tuesday [6] - Lucyd, Inc (NASDAQ:LUCY) surged 23.3% to $1.90 [6] - BILL Holdings, Inc (NYSE:BILL) gained 14.8% to $53.49 [6] - Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) gained 11.7% to $0.8160 after a 5% decline [6] - DBV Technologies SA – ADR (NASDAQ:DBVT) rose 8.7% to $14.50, confirming completion of Phase 3 treatment phase for VIASKIN peanut patch [6] Group 3: Decliners in Pre-Market Trading - MSP Recovery Inc (NASDAQ:MSPR) tumbled 18.2% to $0.46 after a 75% jump on Tuesday [6] - Aspire Biopharma Holdings Inc (NASDAQ:ASBP) declined 16.5% to $0.097 after a 25% dip [6] - Rain Enhancement Technologies Holdco Inc (NASDAQ:RAIN) fell 14.3% to $4.66 after a 10% gain [6] - IRIDEX Corp (NASDAQ:IRIX) shares dipped 13.4% to $1.03 following the announcement of quarterly results [6] - Leifras Co Ltd (NASDAQ:LFS) fell 13.4% to $9.82 after a significant 577% jump on Tuesday [6] - Graphjet Technology (NASDAQ:GTI) fell 12.3% to $3.40 after an 8% decline [6] - ICZOOM Group Inc (NASDAQ:IZM) fell 10.1% to $1.25 after a 34% gain [6] - Biohaven Ltd (NYSE:BHVN) dipped 7.7% to $7.86 after announcing a $150 million offering [6] - Stitch Fix Inc (NASDAQ:SFIX) dipped 4% to $4.21 [6] - Daqo New Energy Corp (NYSE:DQ) fell 3.7% to $34.29 [6]

Core Viewpoint - Universal Display Corp. reported quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $1.19 per share, and down from $1.4 per share a year ago [1][2] Financial Performance - The earnings surprise was -22.69%, with the company previously expected to post earnings of $1.18 per share but actually producing $1.41, resulting in a surprise of +19.49% [2] - Revenues for the quarter ended September 2025 were $139.61 million, missing the Zacks Consensus Estimate by 14.09%, and down from $161.63 million year-over-year [3] Market Performance - Universal Display shares have increased by approximately 0.4% since the beginning of the year, compared to the S&P 500's gain of 15.6% [4] - The company's earnings outlook is crucial for investors, as it reflects current consensus earnings expectations for upcoming quarters [5] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $1.30 on revenues of $174.17 million, and for the current fiscal year, it is $5.18 on revenues of $674.81 million [8] - The estimate revisions trend for Universal Display was favorable prior to the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [7] Industry Context - The Electronics - Miscellaneous Components industry, to which Universal Display belongs, is currently in the top 20% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [9]

Core Viewpoint - LightPath Technologies' stock surged 13.5% after meeting revenue targets for fiscal Q4 2025, despite reporting a significant earnings miss with a loss of $0.16 per share, which was four times worse than analyst expectations [1][3][7]. Revenue and Earnings Summary - LightPath reported revenue of $12.2 million for Q4 2025, achieving a 41% year-over-year growth [3][5]. - Operating costs increased by 52%, leading to a tripling of losses year-over-year to $7.2 million [3][4]. Investor Sentiment and Future Outlook - Investors are optimistic about LightPath's potential for improved efficiency and operating leverage, despite the current earnings miss [4][6]. - The company secured an $18.2 million purchase order for infrared cameras in Q4, with additional orders of $22.1 million expected for 2027, indicating sustained revenue growth [5][6].